PrIME Biologics Pte Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PrIME Biologics Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12369
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PrIME Biologics Pte Ltd (PrIME Biologics) is a biotechnology company that develops and manufactures plasma products for human use. The company uses Preparative Isolation by Membrane Electrophoresis ((PrIME) technology, a disposable, fully-scalable and modular manufacturing process, to manufacture its products. It also carries out employing the natural charge found on proteins of various organisms. PrIME process facilitates the hugely selective purification of the target molecules. The company’s cellular membranes in nature also consist of a charge, indicating that pathogens such as viruses and bacteria can also be selectively eliminated by this system. Its manufacturing plasma based therapeutic proteins for various uses. PrIME Biologics operates in Singapore and Australia. PrIME Biologics is headquartered in Singapore.

PrIME Biologics Pte Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
PrIME Biologics Raises USD12.5 Million in Venture Financing 9
Private Equity 10
PrIME Biologics To Raise US$12 Million In Private Equity Financing 10
PrIME Biologics To Raise US$15.8 Million In Private Equity Financing 11
Acquisition 12
A-Bio Pharma To Acquire 10% Stake In PrIME Biologics From NuSep For US$4.8 Million 12
PrIME Biologics Pte Ltd – Key Competitors 13
PrIME Biologics Pte Ltd – Key Employees 14
PrIME Biologics Pte Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Key Facts 2
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
PrIME Biologics Raises USD12.5 Million in Venture Financing 9
PrIME Biologics To Raise US$12 Million In Private Equity Financing 10
PrIME Biologics To Raise US$15.8 Million In Private Equity Financing 11
A-Bio Pharma To Acquire 10% Stake In PrIME Biologics From NuSep For US$4.8 Million 12
PrIME Biologics Pte Ltd, Key Competitors 13
PrIME Biologics Pte Ltd, Key Employees 14

List of Figures
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PrIME Biologics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[PrIME Biologics Pte Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oberg Industries Inc:企業の戦略的SWOT分析
    Oberg Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Salvatore Ferragamo SpA (SFER):企業の財務・戦略的SWOT分析
    Salvatore Ferragamo SpA (SFER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Godrej Consumer Products Limited:企業のM&A・事業提携・投資動向
    Godrej Consumer Products Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Godrej Consumer Products Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Marmen Inc:企業の戦略的SWOT分析
    Marmen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Sierra Oncology Inc (SRRA):医療機器:M&Aディール及び事業提携情報
    Summary Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a clinical stage drug development company that develops and commercializes DNA damage response therapeutics for the treatment of cancer. The company’s product candidate includes SRA737, an orally bioavailable small mo …
  • Celtic Healthcare Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celtic Healthcare Inc (Celtic), a subsidiary of Graham Holdings Company is a healthcare service provider that offers homecare, hospice, and virtual care services. The center’s hospice services include 24-hour on-call nursing services; physical, emotional, and spiritual assessment, care, supp …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (ERYTECH Pharma) is a clinical-stage biopharmaceutical company developing red blood cell-based therapeutics for cancer and orphan diseases. Its pipeline product candidates include erymethionase (methionine-?-lyase), a novel amino acid agent targeting cancer metabolism in so …
  • Radboud University Medical Centre:製薬・医療:M&Aディール及び事業提携情報
    Summary Radboud University Medical Centre (Radboud UMC), a subsidiary of Radboud University, is a university medical center that offers patient care, education, research, and scientific training services. The centre’s patient care services include basic care, tertiary care, top referral care, and tr …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Veritas (India) Ltd:企業の戦略・SWOT・財務分析
    Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • BioTime Inc (BTX)-製薬・医療分野:企業M&A・提携分析
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • HNI Corporation:企業の戦略・SWOT・財務情報
    HNI Corporation - Strategy, SWOT and Corporate Finance Report Summary HNI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Micro Labs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, aml …
  • Maxim Integrated Products, Inc.:企業の戦略・SWOT・財務分析
    Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Dakota Gasification Co:企業の戦略的SWOT分析
    Dakota Gasification Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Episurf Medical AB (EPIS B):企業の製品パイプライン分析
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. It offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, Episealer …
  • OBJ Ltd (OBJ):企業の財務・戦略的SWOT分析
    Summary OBJ Ltd (OBJ) is a developer of magnetic micro-array drug and ingredient delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and pre-commer …
  • Kedrion SpA-製薬・医療分野:企業M&A・提携分析
    Summary Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company’s products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products …
  • Foxconn Technology Co Ltd
    Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Matinas BioPharma Holdings Inc (MTNB):製薬・医療:M&Aディール及び事業提携情報
    Summary Matinas BioPharma Holdings Inc (Matinas BioPharma) is a clinical-stage biopharmaceutical company that discovers and develops anti-infectives for orphan indications. The company develops lipid nano-crystal (LNC) technology, a drug delivery platform to deliver various molecules such as small m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆